These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7597079)

  • 1. The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide.
    Zacharias M; Hagerman PJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6052-6. PubMed ID: 7597079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat protein is able to efficiently transactivate the HIV-2 LTR through a TAR RNA element lacking both dinucleotide bulge binding sites.
    Rhim H; Rice AP
    Virology; 1995 Jan; 206(1):673-8. PubMed ID: 7831824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure.
    Delling U; Reid LS; Barnett RW; Ma MY; Climie S; Sumner-Smith M; Sonenberg N
    J Virol; 1992 May; 66(5):3018-25. PubMed ID: 1560535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional significance of the dinucleotide bulge in stem-loop1 and stem-loop2 of HIV-2 TAR RNA.
    Rhim H; Rice AP
    Virology; 1994 Jul; 202(1):202-11. PubMed ID: 8009832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
    Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N
    Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulge-induced bends in RNA: quantification by transient electric birefringence.
    Zacharias M; Hagerman PJ
    J Mol Biol; 1995 Mar; 247(3):486-500. PubMed ID: 7536250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
    J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragments of the HIV-1 Tat protein specifically bind TAR RNA.
    Weeks KM; Ampe C; Schultz SC; Steitz TA; Crothers DM
    Science; 1990 Sep; 249(4974):1281-5. PubMed ID: 2205002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.
    Sumner-Smith M; Roy S; Barnett R; Reid LS; Kuperman R; Delling U; Sonenberg N
    J Virol; 1991 Oct; 65(10):5196-202. PubMed ID: 1895380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.
    Alonso A; Cujec TP; Peterlin BM
    J Virol; 1994 Oct; 68(10):6505-13. PubMed ID: 8083988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.
    Neenhold HR; Rana TM
    Biochemistry; 1995 May; 34(19):6303-9. PubMed ID: 7756257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for conserved Arg52 residue for interaction of the human immunodeficiency virus type 1 trans-activation responsive element with trans-activator of transcription protein (49-57). Capillary electrophoresis mobility shift assay.
    Mucha P; Szyk A; Rekowski P; Barciszewski J
    J Chromatogr A; 2002 Aug; 968(1-2):211-20. PubMed ID: 12236505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.